SNUBI Research ::   (262 talks satisfying Presenter = ӿ)
All  Seminar  BioEMR  xMutant  SysBiol  MAInfo  J.Club  TopicSem  BookReading    This week    Help

ADD NEW USER

:   ǥ:    /Ű:    ¥:   

2023-02:
06 ӿ   TopicSem
11 ӿ Mono- and biallelic variant effects on disease at biobank scale     J.Club

2023-01:
02 ӿ Analysis of metastatic potential by somatic mutations in cancer cell  TopicSem

2022-12:
08 ӿ   TopicSem
17 ӿ Genetic risk factors have a substantial impact on healthy life years      J.Club

2022-11:
05 ӿ Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response     J.Club

2022-10:
31 ӿ Identifying Gene combination affecting Cancer patients’ Survival  TopicSem

2022-09:
01 ӿ Association between IRF2BP1-rs60158447 and incidence of post ERCP pancreatitis.   TopicSem
29 ӿ Identifying candidate variants of PEP in merged dataset with new PSM control  TopicSem

2022-08:
27 ӿ Improved pathogenicity prediction for rare human missense variants     J.Club

2022-07:
09 ӿ Identification of discriminative gene-level and protein-level features associated with pathogenic gain-of-function and loss-of-function variants      J.Club
21 ӿ Analysis of validation samples of Post-ERCP pancreatitis  TopicSem
28 ӿ Immune checkpoint inhibitor therapy response data   MAInfo

2022-06:
23 ӿ Analysis of validation samples of Post-ERCP pancreatitis  TopicSem

2022-05:
21 ӿ Pangenome-based genome inference allows efficient and accurate genotyping across a wide spectrum of variant classes     J.Club
30 ӿ Identifying candidate variants of PEP in validaiton dataset  TopicSem

2022-04:
14 ӿ MSK-MET, a cohort of over 25,000 patients with metastasis across 50 cancer types.   MAInfo
25 ӿ Genetic variants associated with post-ERCP pancreatitis (PEP)  TopicSem

2022-03:
03 ӿ Project Score / Opentargets review and data curation   MAInfo
07 ӿ Genetic variants associated with post-ERCP pancreatitis (PEP)  TopicSem
19 ӿ A pan-cancer landscape of somatic mutations in non-unique regions of the human genome     J.Club
28 ӿ   TopicSem

2022-02:
10 ӿ TopicSem
19 ӿ The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets     J.Club

2022-01:
06 ӿ   TopicSem

2021-12:
04 ӿ Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology      J.Club
13 ӿ   TopicSem

2021-11:
22 ӿ Polymorphism affecting Tacrolimus flat peak  TopicSem

2021-10:
02 ӿ Rare variant contribution to human disease in 281,104 UK Biobank exomes     J.Club
07 ӿ Cancer register in UKB  MAInfo
14 ӿ Case reconstruction by candidate variants for PEP patients  TopicSem

2021-09:
06 ӿ Polymorphism affecting Tacrolimus flat peak  TopicSem

2021-08:
02 ӿ Polymorphism affecting Tacrolimus flat peak  TopicSem
02 ӿ Molecular Features for subgrouping cancer patients   MAInfo
07 ӿ Pathogenic missense protein variants affect different functional pathways and proteomic features than healthy population variants     J.Club

2021-06:
28 ӿ WES analysis of post-ERCP pancreatitis patients  TopicSem

2021-05:
12 ӿ Association IRF2BP1 gene and Pancreatitis  MAInfo
13 ӿ WES analysis of post-ERCP pancreatitis patients   TopicSem
29 ӿ Evaluating the molecular diagnostic yield of joint genotyping–based approach for detecting rare germline pathogenic and putative loss-of-function variants  J.Club

2021-04:
03 ӿ Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers     J.Club
12 ӿ WES analysis of post-ERCP pancreatitis patients   TopicSem
15 ӿ MSI analysis in Cancer.   MAInfo

2021-03:
15 ӿ WES analysis of post-ERCP pancreatitis patients  TopicSem
23 ӿ Synthetic Cancer Survival  Seminar

2021-02:
22 ӿ WES analysis of post-ERCP pancreatitis patients  TopicSem
25 ӿ metmap  MAInfo

2021-01:
02 ӿ Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants     J.Club
11 ӿ Polymorphism affecting Tacrolimus flat peak  TopicSem
28 ӿ Variants comparison with two calling methods in tacrolimus samples  TopicSem
30 ӿ e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks     J.Club

2020-12:
21 ӿ Synthetic Association with ERCC6-rs2228528 in Pancreatic Cancer   TopicSem
24 ӿ Comparison deleteriousness between germline and somatic variants in cancer   MAInfo

2020-11:
05 ӿ Germline variants associated with prognosis and drug response in pancreatic cancer patients  TopicSem
07 ӿ Phase and context shape the function of composite oncogenic mutations       J.Club
26 ӿ pancreatic cancer WES analysis  MAInfo
30 ӿ DNA Damaging Repair (DDR) gene Enrichment and Synthetic Association in Pancreatic Cancer   TopicSem

2020-10:
12 ӿ Identifying genetic variants that affect pancreatic cancer patients survival  TopicSem
29 ӿ Summary of Pancreatic cancer data analysis   MAInfo

2020-09:
12 ӿ A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities     J.Club
14 ӿ Identifying genetic variants that affect pancreatic cancer patients survival  TopicSem
17 ӿ Identifying genetic variant associated FOLFIRINOX regimen  MAInfo

2020-08:
13 ӿ Pancreatic Cancer with New-onset Diabetes Mellitus  TopicSem
13 ӿ Affecting FOLFIRINOX sensitivity(CAP grade) variants  MAInfo

2020-07:
09 ӿ CAP grade analysis  MAInfo
13 ӿ Genetic polymorphism affecting FOLFIRINOX response in pancreatic cancer patients  TopicSem
25 ӿ A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer     J.Club

2020-06:
11 ӿ Variant Analysis with Pancreatic cancer FNA sample  MAInfo
22 ӿ Concentration ratio of tacrolimus as indicator in follow-up of patients received transplant   TopicSem
25 ӿ Drug response & Prognosis measurement in Cancer Research   MAInfo

2020-05:
09 ӿ A reference map of the human binary protein interactome     J.Club
14 ӿ Progression of tacrolimus study  MAInfo
18 ӿ Cpeak/C0 as indicator in follow-up of patients received transplant  TopicSem

2020-04:
09 ӿ Comparison variants between TSVC and GATK pipeline  MAInfo
20 ӿ Pancreatic cancer sample with FNA WXS Analysis  TopicSem

2020-03:
05 ӿ Pan-Cancer Analysis of Whole Genomes (PCAWG) project.   MAInfo
14 ӿ Identification of cancer driver genes based on nucleotide context     J.Club
26 ӿ Variant analysis in tacrolimus PK genes  TopicSem

2020-02:
27 ӿ Identification of genomic markers affecting sentivity of tacrolimus   TopicSem

2020-01:
04 ӿ The mutational footprints of cancer therapies     J.Club
09 ӿ Genetic polymorphism influences the pharmacokinetics of tacrolimus  MAInfo
13 ӿ Genetic polymorphism influences the pharmacokinetics of tacrolimus  TopicSem

2019-12:
09 ӿ Genetic polymorphism influences the pharmacokinetics of tacrolimus  TopicSem

2019-11:
04 ӿ tacrolimus sensitivity analysis with clinical variables  TopicSem
09 ӿ Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype     J.Club

2019-10:
21 ӿ Identification of genomic markers affecting sentivity of tacrolimus  Seminar

2019-09:
05 ӿ Networks of Cancer Gene 6.0  MAInfo
26 ӿ Tacrolimus high peaks variant analysis  TopicSem

2019-08:
03 ӿ RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues     J.Club
12 ӿ FNA 3° м  TopicSem

2019-07:
04 ӿ National Omics Data Encyclopedia (NODE) review   MAInfo
08 ӿ Tacrolimus sample sequencing summary  TopicSem

2019-05:
09 ӿ Cancer Dependency Map  MAInfo
25 ӿ Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens     J.Club
30 ӿ SCS in public cellline data   TopicSem

2019-04:
25 ӿ somatic mutation filtering in tumor-only sequencing data  TopicSem

2019-03:
18 ӿ Pancreatic cancer FNA 2° sample м  TopicSem
21 ӿ Installation and Run of Neopepsee   MAInfo
23 ӿ Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer     J.Club

2019-01:
03 ӿ HCMDB data curation  MAInfo
19 ӿ A map of constrained coding regions in the human genome     J.Club
31 ӿ Distribution of population frequency and SIFT/Gene Score in in SCS genes  TopicSem

2018-12:
24 ӿ Relation between SCS and metastasis  TopicSem
26 ӿ Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden in Lung Adenocarcinoma  Seminar

2018-11:
03 ӿ Network Propagation Predicts Drug Synergy in Cancers     J.Club
22 ӿ Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden in Lung Adenocarcinoma  TopicSem

2018-10:
11 ӿ Variants calling workflow with GATK4   MAInfo
25 ӿ Identification of SCS pairs in public pancreatic cancer data  TopicSem

2018-09:
08 ӿ Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer     J.Club
13 ӿ Features associated immune checkpoint inhibitor  TopicSem

2018-08:
06 ӿ SCS analysis in Pancreatic cancer  TopicSem

2018-07:
05 ӿ Characteristics of germline SCS pair   TopicSem
07 ӿ Systematic analysis of complex genetic interactions     J.Club

2018-06:
07 ӿ TMB and Tumor immune in SCS  TopicSem
18 ӿ pVACseq:A cancer immunotherapy pipeline for identifying and prioritizing neoantigens from a list of tumor mutations  MAInfo

2018-04:
05 ӿ GDM analytics  TopicSem
21 ӿ Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics      J.Club
22 ӿ Moonlight: a tool for biological interpretation and driver genes discovery  MAInfo
30 ӿ GDM Analytics Annotation DB  TopicSem

2018-02:
05 ӿ Drug sensitivity and SCS   TopicSem
08 ӿ OT & CTRP(Cancer Therapeutics Response Portal) review  MAInfo

2018-01:
08 ӿ SCS analysis in MSI colon cancer  TopicSem
25 ӿ The most studies genes of all time and of any time  xMutant
27 ӿ Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy     J.Club

2017-12:
06 ӿ Re-analysis of SCS in colon cancer  TopicSem
14 ӿ Project DRIVE: deep RNAi interrogation of viability effects in cancer  xMutant
27 ӿ Network of Cancer genes 5.0   MAInfo

2017-11:
02 ӿ Graphtyper: enables population-scale genotyping using pangenome graphs  xMutant
08 ӿ SCS analysis in TCGA coad and cell lines data  TopicSem
08 ӿ tcga followup clinical data   MAInfo
25 ӿ Comprehensive Analysis of Hypermutation in Human Cancer     J.Club

2017-09:
05 ӿ The Mutational Spectrum of MSI Events and MMR Genes in previous studies  xMutant
09 ӿ Integrative clinical genomics of metastatic cancer     J.Club
13 ӿ Public Cell lines databases  MAInfo
25 ӿ Drug sensitivity in SCS genes  TopicSem

2017-08:
16 ӿ SCS analysis in Colon cancer cell lines   TopicSem

2017-07:
08 ӿ A global genetic interaction network maps a wiring diagram of cellular function     J.Club
12 ӿ SAFE: Spatial Analysis of Functional Enrichment  xMutant
17 ӿ Aggregate DNAmethylation to gene scale  TopicSem
19 ӿ methHC: A database of DNA Methylation and gene expression in Human Cancer  MAInfo

2017-06:
12 ӿ Synthetic Cancer Survival relationship between DNA methylation and mutation  TopicSem

2017-05:
10 ӿ PARP inhibitors: Synthetic lethality in the clinic  xMutant
15 ӿ Never-smoker LUAD analysis  TopicSem
31 ӿ somatic mutation aggregation workflow used to generate both the public and protected MAFs in the GDC DNA-Seq pipelines.   MAInfo

2017-04:
29 ӿ Reassessment of Genomic Sequence Variation to Harmonize Interpretation for Personalized Medicine     J.Club

2017-03:
27 ӿ TCGA never smoker LUAD mutation profile  TopicSem

2017-02:
08 ӿ SMC lung cancer data analysis result  TopicSem
18 ӿ Somatic Mutation Patterns in Hemizygous Genomic Regions Unveil Purifying Selection during Tumor Evolution     J.Club

2017-01:
02 ӿ Analysis plan of SMC lung cancer data.  TopicSem
25 ӿ Influence of Co-occurring Mutations on Clinical Outcomes in leukemia  MAInfo
25 ӿ SMC lung cancer data м  xMutant

2016-11:
21 ӿ Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden   TopicSem
26 ӿ Exploring genetic suppression interactions on a global scale     J.Club
30 ӿ overview of gain of function studies  MAInfo
30 ӿ Loss-of-function genetic tools for animal models: cross-species and cross-platform differences  xMutant

2016-10:
05 ӿ Pembrolizumab MSKCC data analysis  MAInfo
05 ӿ LUAD acs-mutation/expression analysis  xMutant
19 ӿ Differential characteristics among SCS burden groups   TopicSem

2016-09:
03 ӿ A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy     J.Club

2016-08:
01 ӿ Analysis colon cancer in ICGC data  xMutant
03 ӿ Types of measures of prognosis  MAInfo
19 ӿ Identification of combinatory mutational effect between genes for patient survival in colon cancer     Seminar
29 ӿ Identification of SCS and SCS burden in multiple cancer  TopicSem

2016-07:
18 ӿ Identification SCS in COAD  TopicSem

2016-06:
08 ӿ Identification of co-methylation patterns in COAD   TopicSem
13 ӿ Simple example for using Mutect2  xMutant
17 ӿ The summary of TARGET project and NCI Genomc Data Commons (GDC)  MAInfo
25 ӿ Characterizing genomic alterations in cancer by complementary functional associations     J.Club

2016-05:
09 ӿ Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden   TopicSem

2016-04:
09 ӿ Identification of neutral tumor evolution across cancer types     J.Club
18 ӿ Lung cancer cell line data processing  xMutant
29 ӿ Pharmacogenomic agreement between two cancer cell line data sets  MAInfo

2016-03:
11 ӿ Microsatellite instability in colorectal cancer—the stable evidence  MAInfo
23 ӿ Identification prognosis of patients with MSI in COAD  TopicSem

2016-02:
23 ӿ Patterns and functional implications of rare gremlin variants across 12 cancer types  xMutant
29 ӿ Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden in Multiple Cancer  TopicSem

2016-01:
09 ӿ A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing     J.Club
18 ӿ   MAInfo
20 ӿ SCS paper modified Figures and Table.  TopicSem
25 ӿ APBC 2016 review  Seminar
28 ӿ TCGA data status summary (renewal)  MAInfo

2015-12:
14 ӿ Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden in Multiple Cancer  TopicSem

2015-11:
02 ӿ Identification of Synthetic Cancer Survival and Synthetic Cancer Survival burden in multiple Cancer    TopicSem
14 ӿ An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer     J.Club

2015-09:
30 ӿ Lung cancer cell line sequence analysis  TopicSem

2015-08:
12 ӿ Figures & Tables for SS study  TopicSem
15 ӿ The Human Phenotype Ontology (HPO)   xMutant
29 ӿ Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities     J.Club

2015-07:
06 ӿ Identification of Synthetic Survival and Synthetic Survival burden in multiple Cancer  TopicSem

2015-06:
03 ӿ Patient survival trends of synthetic survival burden   TopicSem

2015-05:
06 ӿ Identification of synthetic survival genes with survival analysis  TopicSem
16 ӿ Assessing the clinical utility of cancer genomic and proteomic data across tumor types     J.Club

2015-04:
04 ӿ Cox regression with Penalized likelihood   xMutant

2015-03:
13 ӿ Predicting effects of indels  xMutant
28 ӿ A method for calculating probabilities of fitness consequences for point mutations across the human genome     J.Club
30 ӿ Identification of potential synthetic lethal genes with survival analysis  TopicSem

2015-02:
16 ӿ Identification of potential synthetic lethal gene pairs.   TopicSem

2015-01:
12 ӿ Identification of potential synthetic lethal gene pairs.  TopicSem
24 ӿ Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complex      J.Club
26 ӿ sg13  Seminar

2014-12:
17 ӿ Identificiation of potential synthetic lethal genes with survival analysis   TopicSem
19 ӿ SKCM analysis result  xMutant

2014-11:
05 ӿ SG13 exome interpretation  Seminar
08 ӿ Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene     J.Club
21 ӿ Variant scores(SIFT, Polphen2..) in CFTR2 database variants  xMutant

2014-10:
06 ӿ Identifying potential synthetic lethal genes   TopicSem
10 ӿ ICGC LUSC Data analysis  xMutant
27 ӿ Identificiation of potential synthetic lethal genes with survival analysis  TopicSem

2014-09:
06 ӿ Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality     J.Club
19 ӿ Syn-lethality: An Integrative Knowledge Base of Synthetic Lethality   xMutant
29 ӿ Identification of potential synthetic lethal genes   TopicSem

2014-08:
04 ӿ Identification of potential synthetic lethals gene using mutation and clinical data in TCGA   TopicSem
14 ӿ Overview of Gene Ontology and its application  xMutant

2014-07:
16 ӿ Identification of potential synthetic lethals gene using mutation and clinical data in TCGA   TopicSem
16 ӿ Condition and application of cox proportional hazard model  xMutant
26 ӿ ISMB review: Dissecting cancer heterogeneity with a probabilistic genotype-phenotype model     J.Club

2014-06:
11 ӿ Identification of potential synthetic lethals gene using mutation and clinical data in TCGA   TopicSem
28 ӿ A general framework for estimating the relative pathogenicity of human genetic variants.     J.Club

2014-05:
08 ӿ Permutation test to compare survival curves and result  xMutant
19 ӿ Survival analysis with cox proportional hazard model and permutation  TopicSem
29 ӿ Identification of potential synthetic lethals gene using mutation and clinical data   xMutant
30 ӿ Identification of potential synthetic lethals gene using mutation and clinical data  Seminar

2014-04:
14 ӿ Identification of potential synthetic lethal genes in 12 tumor types  TopicSem
26 ӿ Identification of synthetic lethal pairs in biological systems through network information centrality     J.Club

2014-03:
06 ӿ Identification of synthetic lethal genes in 12 major cancer types   xMutant
19 ӿ Identification potential synthetic lethal genes in cancer / CADD review  TopicSem

2014-02:
11 ӿ Identification of synthetic lethal genes in 12 major cancer types   xMutant
15 ӿ Discovery and saturation analysis of cancer genes across 21 tumour types     J.Club
17 ӿ Identification of synthetic lethal genes in 12 major cancer types   TopicSem

2014-01:
22 ӿ Synthetic Lethality Analysis in TCGA BRCA somatic mutation data   TopicSem

2013-12:
03 ӿ Workflow and result of survival analysis in TCGA, BRCA.  xMutant
04 ӿ Synthetic Lethality Analysis of BRCA   TopicSem
07 ӿ Integrative annotation of variants from 1092 humans: application to cancer genomics.     J.Club
23 ӿ Synthetic Lethality Analysis of BRCA   TopicSem
31 ӿ mutation analysis of TCGA LUSC data  xMutant

2013-11:
26 ӿ Synthetic Lethality Analysis of BRCA  xMutant

2013-10:
16 ӿ SNPChase: correcting errors from diverse literatures and SNV databases   TopicSem
19 ӿ Discovery Analysis of TCGA Data Reveals Association between Germline Genotype and Survival in Ovarian Cancer Patients  J.Club
30 ӿ TCGA germline mutation data : summary  TopicSem

2013-09:
03 ӿ Available public genomes for preprocessing: SIFT/PP2 Score  xMutant
04 ӿ SNPChase: correcting errors from diverse literatures and SNV databases  TopicSem
17 ӿ TCGA germline data labeling  xMutant

2013-08:
22 ӿ DNMT3A in OMIM  MAInfo
31 ӿ   J.Club

2013-07:
04 ӿ Characteristics of DNA methylation depending on cancer types  MAInfo
06 ӿ CpG island shore methylation regulates caveolin-1 expression in breast cancer       J.Club
10 ӿ SNPChase: correcting errors from diverse literatures and SNV databases  TopicSem
12 ӿ SNPChase: correcting errors from diverse SNV databases for SNVs  Seminar
23 ӿ Characteristics of DNA methylation depending on cancer type(TCGA data)  xMutant
31 ӿ SNPChase: correcting errors from diverse literatures and SNV databases  TopicSem

2013-06:
10 ӿ SNPChase: correcting errors from diverse SNV databases for SNVs   TopicSem

2013-05:
11 ӿ DNA co-methylation analysis suggests novel functional associations between gene pairs in breast cancer samples     J.Club
14 ӿ Resources for Cancer Genome: COSMIC  xMutant
22 ӿ SNPChase: correcting errors from diverse SNV databases for SNVs  TopicSem
23 ӿ Genes regulating DNA methylation   MAInfo
30 ӿ Patterns of Methylation Status and Somatic mutations in Cancer Genome  xMutant

2013-04:
02 ӿ TCGA Data Primer: Barcode and Patient ID  xMutant
08 ӿ Plan for analyzing methylation & expression data in TCGA  TopicSem
23 ӿ Review previous studies for methylation-expression relationship   xMutant
24 ӿ Review previous studies for methylation-expression relationship  TopicSem

2013-03:
20 ӿ Analyzing DNA methylation regulation in cancers  TopicSem
26 ӿ DNA Methylation in TCGA Data and its Structure.  xMutant
30 ӿ Identification of markers associated with global changes in DNA methylation regulation in cancers       J.Club

powered by SNUBI